Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis

BACKGROUND: Both the US FDA and the European Medicines Agency (EMA) have approved aripiprazole for use in adolescents for specific indications. Given the assumed favorable side-effect profile of aripiprazole, its use in children and adolescents has increased for both official and off-label indicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernagie, Chiara, Danckaerts, Marina, Wampers, Martien, De Hert, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996892/
https://www.ncbi.nlm.nih.gov/pubmed/27395403
http://dx.doi.org/10.1007/s40263-016-0367-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996892/
https://www.ncbi.nlm.nih.gov/pubmed/27395403
http://dx.doi.org/10.1007/s40263-016-0367-y

Ejemplares similares